JY
ENTX icon

Jeff Yass’s Entera Bio ENTX Stock Holding History

Jeff Yass’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-64,910
Closed -$126K – 13389
2025
Q4 		$126K Sell
64,910
-2,267
-3% -$5.32K ﹤0.01% 11314
2025
Q3 		$129K Buy
67,177
+18,300
+37% +$35K ﹤0.01% 11400
2025
Q2 		$92.9K Buy
48,877
+14,111
+41% +$27.9K ﹤0.01% 11839
2025
Q1 		$59.1K Sell
34,766
-3,633
-9% -$7.9K ﹤0.01% 11801
2024
Q4 		$80.3K Buy
38,399
+17,741
+86% +$33.1K ﹤0.01% 11468
2024
Q3 		$39.3K Sell
20,658
-8,198
-28% -$14.5K ﹤0.01% 11465
2024
Q2 		$53.1K Sell
28,856
-22,772
-44% -$49.8K ﹤0.01% 11388
2024
Q1 		$86.2K Buy
+51,628
New +$57K ﹤0.01% 11297
2021
Q3 		– Sell
-66,733
Closed -$342K – 12905
2021
Q2 		$399K Buy
+66,733
New +$247K ﹤0.01% 10141

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Jeff Yass's ENTX Position: Q1 2026 in Review

Jeff Yass sold out of Entera Bio (ENTX) in Q1 2026, closing a stake of 64,910 shares — an estimated $126K sold.

Jeff Yass first reported a position in ENTX in Q2 2021 and held it in 9 quarters. The position peaked at $399K in Q2 2021. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • Jeff Yass reported no remaining Entera Bio position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 64,910 Entera Bio shares in Q1 2026, an estimated $126K.
  • Jeff Yass first reported a position in Entera Bio in Q2 2021 and held it in 9 quarters.
  • Jeff Yass's Entera Bio position peaked at $399K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.